Avinger Inc is a United States-based company. The Company operates as a medical device company that designs, manufactures, and sells image-guided, catheter-based systems for treating peripheral artery disease (PAD). Its products are used by interventional cardiologists, vascular surgeons, and interventional radiologists in the United States and select international markets and are based on its Lumivascular platform, a system that uses optical coherence tomography (OCT) for real-time visualization inside arteries. Its products includes the Lightbox imaging console, Ocelot and Tigereye catheters for crossing blockages, and Pantheris for removing plaque.

Employees

Sector

Advanced Medical Equipment & Technology

More about the company

Income Statement and Estimates

More financial data

Market Closed - Nasdaq Other stock markets 01:00:00 15/02/2025 +04			5-day change	1st Jan Change
0.4740 ^USD	-20.74%		-.--%	-

20/02/25	Avinger, Inc.(NasdaqCM:AVGR) dropped from S&P TMI Index	CI
17/02/25	Avinger, Inc.(NasdaqCM:AVGR) dropped from NASDAQ Composite Index	CI

Market Cap	2.71M 2.36M 2.19M 2.05M 3.84M 255M 3.86M 25.93M 10.05M 126M 10.16M 9.94M 437M	P/E 2022	-0.25x	P/E 2023	-0.19x
Enterprise Value	12.83M 11.18M 10.36M 9.7M 18.19M 1.21B 18.3M 123M 47.62M 596M 48.15M 47.12M 2.07B	EV / Sales 2022	1.19x	EV / Sales 2023	1.78x
Free-Float	88.44%	Yield 2022 *	-	Yield 2023	-

20/02/25	Avinger, Inc.(NasdaqCM:AVGR) dropped from S&P TMI Index	CI
17/02/25	Avinger, Inc.(NasdaqCM:AVGR) dropped from NASDAQ Composite Index	CI
11/02/25	Avinger Inc Terminated Employment Of Each Of Jeffrey M. Soinski, Co's CEO And Nabeel Subainati, Vice President, Finance	RE
11/02/25	Avinger, Inc. Announces Termination of the Employment of Jeffrey M. Soinski, Chief Executive Officer	CI
11/02/25	Avinger, Inc. Announces Executive Changes	CI
24/12/24	Wall Street Set to Open Mixed Tuesday Ahead of Holiday Break	MT
24/12/24	US Futures Tread Water Ahead of Holiday Break	MT
23/12/24	Iberdrola Completes Merger with Avangrid	MT
08/11/24	Avinger, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	CI
08/11/24	Earnings Flash (AVGR) AVINGER Reports Q3 Loss $-1.82	MT
08/11/24	Earnings Flash (AVGR) AVINGER Posts Q3 Revenue $1.7M	MT
08/11/24	Avinger, Inc., Q3 2024 Earnings Call, Nov 07, 2024
04/10/24	Wall Street Set to Open Higher Friday on Strong Employment Data	MT

21/04/23	HC Wainwright Starts Avinger at Buy With $1.60 Price Target	MT
11/05/22	B. Riley Lowers Avinger's Price Target to $9 from $11, Keeps Buy Rating	MT
18/03/22	B. Riley Adjusts Avinger's Price Target to Post-Split $11 from $40, Expects Omicron Impact Late in Q4, Into Q1; Keeps Buy Rating	MT
29/06/21	AVINGER : B. Riley Starts Avinger at Buy with $2.50 PT, Says Well-Positioned to Execute on Growth Strategy	MT

Avinger, Inc. Stock

Stocks

AVGR

US0537348775

Advanced Medical Equipment & Technology

Valuation: Avinger, Inc.

Latest news : Avinger, Inc.

Analysts' recommendations: Avinger, Inc.

Press Releases: Avinger, Inc.

Quotes and Performance

Course Extremes

Managers and Directors: Avinger, Inc.

Latest insider transactions

Medical Imaging Systems

Financials

Company Profile

Income Statement and Estimates

02/01/25	Avinger : Private Placement Form 8 K	PU
08/11/24	Avinger : Quarterly Report for Quarter Ending September 30, 2024 (Form 10-Q)	PU
08/11/24	Avinger : Reports Third Quarter 2024 Results Form 8 K	PU
08/11/24	Avinger: Q3 Earnings Snapshot	AQ
25/10/24	Avinger Releases Updated Data from IMAGE-BTK in Webinar Featuring Key Opinion Leaders in the Field of Vascular Intervention	AQ

Manager	Title	Age	Since
Karina Yamamoto CEO	Chief Executive Officer	-	-
Thomas Davis CTO	Chief Tech/Sci/R&D Officer	-	05/08/2024

Date	Insider	Type	Main position	Quantity	% Market Cap.
23/01/25	Himanshu Patel	Sell	Founder	2,215	0.0669%
23/01/25	Nabeel Subainati	Sell	Chief Financial Officer	1,255	0.0379%
23/01/25	Jeffrey Soinski	Sell	Chief Executive Officer	3,690	0.1115%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
AVINGER, INC.	-20.74%	-.--%	-.--%	-94.92%	1.52M
SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.	-5.99%	-9.24%	-19.45%	-24.47%	12.54B
IRAY GROUP	-0.26%	+7.72%	+93.53%	+22.87%	5.27B
SONOSCAPE MEDICAL CORP.	-1.04%	-3.45%	-36.22%	-65.08%	1.21B
BEIJING WANDONG MEDICAL TECHNOLOGY CO.,LTD.	+1.69%	-0.95%	-32.67%	-43.30%	1.19B
IRADIMED CORPORATION	+1.22%	-1.50%	+58.31%	+92.56%	1.18B
SHANTOU INSTITUTE OF ULTRASONIC INSTRUMENT CO., LTD.	-0.53%	-3.60%	-37.73%	-	949M
CARERAY DIGITAL MEDICAL TECHNOLOGY CO., LTD.	-5.27%	-1.71%	+213.40%	+194.59%	704M
CAPSOVISION, INC.	+1.69%	-8.07%	-	-	330M
FISCHER MEDICAL VENTURES LIMITED	-0.74%	-0.55%	-57.45%	+200.00%	247M
Average	-3.00%	+0.07%	+20.19%	+35.28%	2.36B
Weighted average by Cap.	-3.31%	-3.87%	+14.39%	-0.95%

	2022	2023
Net sales	8.27M 7.21M 6.68M 6.25M 11.73M 781M 11.8M 79.25M 30.72M 384M 31.05M 30.39M 1.33B	7.65M 6.67M 6.18M 5.78M 10.85M 722M 10.91M 73.3M 28.41M 355M 28.72M 28.11M 1.23B
Net income	-17.62M -15.37M -14.23M -13.32M -24.98M -1.66B -25.14M -169M -65.43M -818M -66.15M -64.73M -2.84B	-18.32M -15.97M -14.79M -13.85M -25.97M -1.73B -26.13M -176M -68.02M -851M -68.77M -67.29M -2.95B
Net Debt	1.76M 1.53M 1.42M 1.33M 2.49M 166M 2.5M 16.82M 6.52M 81.56M 6.59M 6.45M 283M	10.12M 8.82M 8.17M 7.65M 14.35M 955M 14.43M 96.95M 37.57M 470M 37.99M 37.17M 1.63B

3 years	0.36	18
5 years	0.36	438
10 years	0.36	1,000,000